Intellia Therapeutics, Inc. (NTLA) Downgraded to Underperform by Wolfe Research
Rating Change Wolfe Research analysts downgraded Intellia Therapeutics, Inc. (NASDAQ:NTLA) from Peer Perform to Underperform on July 16, 2026. Market Context Intellia…
Read more
